NCT00616200

Brief Summary

The purposes of this study are to prospectively determine the effect of a very low carbohydrate diet on quality of life and gastrointestinal symptoms in patients with diarrhea-predominant irritable bowel syndrome (IBS-D); and to determine possible physiological correlates of symptom improvement, as related to post-prandial 5-hydroxytryptamine (5-HT) release, weight loss and fiber content.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 15, 2008

Completed
1.5 years until next milestone

Study Start

First participant enrolled

August 1, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

November 11, 2011

Completed
Last Updated

October 16, 2017

Status Verified

October 1, 2011

Enrollment Period

9 months

First QC Date

February 5, 2008

Results QC Date

June 29, 2010

Last Update Submit

September 13, 2017

Conditions

Keywords

D-IBS (diarrhea predominant irritable bowel syndrome)

Outcome Measures

Primary Outcomes (1)

  • Number of Subjects Reporting "Adequate Relief" From IBS Symptoms for the Previous Week. Adequate Relief Was a "True/False" Item.

    Adequate relief was measured as the primary endpoint via a single item Adequate Relief Question asking "Over the past week have you had adequate relief of your symptom experience". Higher scores represent greater levels of adequate relief over the week prior to the assessment. Participants completed this 1-item questionnaire at the end of each of weeks of the study, assessing whether they had adequate relief of their IBS symptoms for the week. A responder was defined as reporting adequate relief in at least 2 of the 4 weeks on the VLCD.

    At the end of each of 6 study weeks

Secondary Outcomes (2)

  • Impact of Very Low Carbohydrate Diet on Stool Frequency

    6 Weeks

  • Sickness Impact Profile

    At the end of four week VLCD

Study Arms (1)

A

EXPERIMENTAL
Other: Very low carbohydrate diet

Interventions

4 weeks on strictly controlled low carbohydrate diet

A

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-70 years old, male or female
  • Meet Rome II Criteria for IBS-D
  • Body mass index \> 25 kg/m\^2
  • Desire to use a very low carbohydrate diet for weight loss
  • Score of \> 36 on the FBDSI
  • Ability to understand consent form
  • In stable health by screening history, physical examination performed by a study physician, laboratory tests (normal blood counts, kidney function tests, liver tests, TSH).

You may not qualify if:

  • Age \< 18 years or age \> 70 years
  • History of inflammatory bowel disease
  • History of any gastrointestinal surgery that preceded the onset of IBS symptoms
  • Pregnancy or breastfeeding
  • FBDSI symptom score of ≤ 36
  • Inability to understand consent form
  • Diabetes requiring medications (must be controlled with diet and exercise alone).
  • Chronic narcotic use for any reason
  • Use of serotonin-selective reuptake inhibitors unless patient has been on a stable dose for at least 4 weeks.
  • Use of any over-the-counter or prescription weight loss medications.
  • Any chronic or unstable diseases (e.g., kidney disease, heart disease, or cancer) that may put the subject at increased risk from the intervention
  • Any of the following baseline abnormalities of laboratory tests or physical exam findings:
  • Serum creatinine \> 1.5 mg/dL in men, \> 1.3 mg/dL in women.
  • Liver disease (AST or ALT \> 2 times the upper limit of normal or total bilirubin \> 1.6mg/dL).
  • Blood pressure \> 160/100 mm Hg.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Center for Functional GI & Motility Disorders

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (1)

  • Austin GL, Dalton CB, Hu Y, Morris CB, Hankins J, Weinland SR, Westman EC, Yancy WS Jr, Drossman DA. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009 Jun;7(6):706-708.e1. doi: 10.1016/j.cgh.2009.02.023. Epub 2009 Mar 10.

Limitations and Caveats

Low N, lack of standard control group and specific overweight/obese female predominant population.

Results Point of Contact

Title
Stephan R. Weinland, Ph.D.
Organization
UNC Center for Functional GI & Motility Disorders

Study Officials

  • Douglas Drossman, MD

    UNC Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2008

First Posted

February 15, 2008

Study Start

August 1, 2009

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

October 16, 2017

Results First Posted

November 11, 2011

Record last verified: 2011-10

Locations